|
1
|
Billroth T and Klinik Chirurgische Wien:
Nebst einem Gesammt-Bericht über die chirurgischen Kliniken in
Zürich und Wien während der Jahre 1860–1876. Erfahrungen auf dem
Gebiet der practischen Chirurgie (Hirschwald Berlin). 1879.(In
German).
|
|
2
|
Tsai S, Nathan H and Pawlik TM: Primary
liver cancer: Intrahepatic cholangiocarcinoma emerges from the
shadows. Updates Surg. 62:5–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shirabe K, Shimada M, Harimoto N,
Sugimachi K, Yamashita Y, Tsujita E and Aishima S: Intrahepatic
cholangiocarcinoma: Its mode of spreading and therapeutic
modalities. Surgery. 131:S159–S164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang J and Yan LN: Current status of
intrahepatic cholangiocarcinoma. World J Gastroenterol.
14:6289–6297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suzuki T, Takahashi H, Yao K, Inagi K,
Nakayama M, Makoshi T, Nagai H and Okamoto M: Multiple primary
malignancies in the head and neck: A clinical review of 121
patients. Acta Otolaryngol Suppl. 547:88–92. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moertel CG: Multiple primary malignant
neoplasms: Historical perspectives. Cancer. 40(Suppl): 1786–1792.
1977. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moertel CG: Incidence and significance of
multiple primary malignant neoplasms. Ann NY Acad Sci.
114:2012.
|
|
8
|
Luciani A and Balducci L: Multiple primary
malignancies. Semin Oncol. 31:264–273. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Poultsides GA, Zhu AX, Choti MA and Pawlik
TM: Intrahepatic cholangiocarcinoma. Surg Clin North Am.
90:817–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jung KS, Chun KH, Choi GH, Jeon HM, Shin
HS, Park YN and Park JY: Synchronous development of intrahepatic
cholangiocarcinoma and hepatocellular carcinoma in different sites
of the liver with chronic B-viral hepatitis: Two case reports. BMC
Res Notes. 6:5202013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Takeuchi Y, Nagata K, Yokota T, Handa M,
Matsunaga H, Nishio Y and Kusugami K: Von Recklinghausen disease
associated with intrahepatic cholangiocarcinoma and ampullary
carcinoid. Nihon Naika Gakkai Zasshi. 90:2467–2469. 2001.(In
Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fwu CW, Chien YC, You SL, Nelson KE, Kirk
GD, Kuo HS, Feinleib M and Chen CJ: Hepatitis B virus infection and
risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A
cohort study of parous women in Taiwan. Hepatology. 53:1217–1225.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Murakami T, Nishikawa H, Koshikawa Y,
Okabe Y, Wakasa T and Osaki Y: Double primary cancers: Intrahepatic
cholangiocarcinoma with myocardial metastases and lung squamous
cell carcinoma. Intern Med. 51:2329–2335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Henderson-Jackson E, Nasir NA, Hakam A,
Nasir A and Coppola D: Primary mixed lymphoepithelioma-like
carcinoma and intra-hepatic cholangiocarcinoma: A case report and
review of literature. Int J Clin Exp Pathol. 3:736–741.
2010.PubMed/NCBI
|
|
15
|
Anthony MP, Mak H and Khong PL: An unusual
case of synchronous renal cell carcinoma in a horseshoe kidney and
intrahepatic cholangiocarcinoma. Clin Nucl Med. 34:922–923. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Palmer WC and Patel T: Are common factors
involved in the pathogenesis of primary liver cancers? A
meta-analysis of risk factors for intrahepatic cholangiocarcinoma.
J Hepatol. 57:69–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tyson GL and El-Serag HB: Risk factors for
cholangiocarcinoma. Hepatology. 54:173–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harrington KD: The management of
acetabular insufficiency secondary to metastatic malignant disease.
J Bone Joint Surg Am. 63:653–664. 1981.PubMed/NCBI
|
|
19
|
Shahid M, Saunders T, Jeys L and Grimer R:
The outcome of surgical treatment for peri-acetabular metastases.
Bone Joint J. 96-B:132–136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hoell S, Dedy N, Gosheger G, Dieckmann R,
Daniilidis K and Hardes J: The Burch-Schneider cage for
reconstruction after metastatic destruction of the acetabulum:
Outcome and complications. Arch Orthop Trauma Surg. 132:405–410.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bester L, Meteling B, Boshell D, Chua TC
and Morris DL: Transarterial chemoembolisation and
radioembolisation for the treatment of primary liver cancer and
secondary liver cancer: a review of the literature. J Med Imaging
Radiat Oncol. 58:341–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Furuse J, Kasuga A, Takasu A, Kitamura H
and Nagashima F: Role of chemotherapy in treatments for biliary
tract cancer. J Hepatobiliary Pancreat Sci. 19:337–341. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Valle J, Wasan H, Palmer DH, Cunningham D,
Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira
SP, et al: ABC-02 Trial Investigators: Cisplatin plus gemcitabine
versus gemcitabine for biliary tract cancer. N Engl J Med.
362:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gruenberger B, Schueller J, Heubrandtner
U, Wrba F, Tamandl D, Kaczirek K, Roka R, Freimann-Pircher S and
Gruenberger T: Cetuximab, gemcitabine, and oxaliplatin in patients
with unresectable advanced or metastatic biliary tract cancer: A
phase 2 study. Lancet Oncol. 11:1142–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Eckmann KR, Patel DK, Landgraf A, Slade
JH, Lin E, Kaur H, Loyer E, Weatherly JM and Javle M: Chemotherapy
outcomes for the treatment of unresectable intrahepatic and hilar
cholangiocarcinoma: A retrospective analysis. Gastrointest Cancer
Res. 4:155–160. 2011.PubMed/NCBI
|
|
26
|
Maithel SK, Gamblin TC, Kamel I,
Corona-Villalobos CP, Thomas M and Pawlik TM: Multidisciplinary
approaches to intrahepatic cholangiocarcinoma. Cancer.
119:3929–3942. 2013. View Article : Google Scholar : PubMed/NCBI
|
